Initial genomic analyses of human glioblastoma and related CNS tumors noted recurring mutations in IDH, encoding isozymes of isocitrate dehydrogenase that catalyze conversion of isocitrate to α-ketoglutarate (α-KG). Here, IDH2 is linked to glioblastoma.